Abstract
Background: The biological mechanisms underlying “chemo brain” or neurobehavioral symptoms in cancer patients are largely unknown, however, an emergent literature links indicators of immune deregulation to these symptoms. We hypothesized higher concentrations of pro-inflammatory cytokine interleukin 6 in breast cancer (BC) patients at both pre and post-treatment assessment relative to healthy controls, and that IL6 levels would be associated with changes in neurobehavioral functioning. Methods: Post-menopausal BC patients were assessed prior to any local or systemic treatment and one month after completion of primary treatment. Age-matched Healthy controls (HC) were assessed at similar time intervals. Neurocognitive, behavioral, and IL6 data for 120 BC and 56 HC were examined. Results: Statistically significant differences in IL6 levels between BC and HC were not evident at baseline but were at follow up assessment, with increased levels in the BC group. Factorial ANCOVA which evaluated pre-post treatment change in the BC and HC groups found that BC patients with higher IL6 levels at baseline had significant declines in selected cognitive functioning relative to the comparison groups, including memory retention ( F (1,155) = 7.07; p = .009) and processing speed ( p = .055). Similar interaction effects were not found on measures of fatigue, mood, or pain. Conclusion: Breast cancer patients with higher IL6 levels prior to treatment appear to be at risk for worse functioning in selected behavioral outcomes following treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.